Health Care & Life Sciences » Biotechnology | IBEX Technologies Inc.

IBEX Technologies Inc. | Balance Sheet

Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,579.60
1,686.90
2,084.80
2,899.60
3,004.60
3,140.40
Total Accounts Receivable
814.40
562.00
721.70
406.80
544.20
718
Inventories
806.20
805.10
824.40
669.60
478.40
345
Other Current Assets
143.20
96.40
100.10
92.00
109.50
90.10
Total Current Assets
3,343.40
3,150.40
3,731.00
4,068.00
4,136.60
4,293.50
Net Property, Plant & Equipment
3,036.40
2,625.60
2,210.00
2,374.60
2,920.30
2,742.20
Intangible Assets
-
-
-
-
34.50
28.80
Other Assets
-
-
438.20
-
-
-
Total Assets
6,379.80
5,776.00
6,927.70
6,811.10
9,601.60
9,458.10
ST Debt & Current Portion LT Debt
33.50
37.10
46.30
48.40
48.30
Accounts Payable
797.10
553.20
492.40
503.70
739.20
Other Current Liabilities
0.00
0.00
0.00
-
0.00
Total Current Liabilities
830.50
590.30
538.70
552.10
787.60
Long-Term Debt
966.40
988.70
1,139.70
1,089.20
993.50
Provision for Risks & Charges
25.00
-
-
-
-
Deferred Taxes
22.80
24.20
29.00
22.50
2,443.30
Total Liabilities
1,844.70
1,603.20
2,255.90
2,032.40
1,848.00
Common Equity (Total)
4,535.20
4,172.80
4,671.80
4,778.70
7,753.70
Total Shareholders' Equity
4,535.20
4,172.80
4,671.80
4,778.70
7,753.70
Total Equity
4,535.20
4,172.80
4,671.80
4,778.70
7,753.70
Liabilities & Shareholders' Equity
6,379.80
5,776.00
6,927.70
6,811.10
9,601.60

About IBEX Technologies

View Profile
Address
5485, rue Pare
Montréal Québec H4P 1P7
Canada
Employees -
Website http://www.ibex.ca
Updated 07/08/2019
IBEX Technologies, Inc. manufactures and markets diagnostic products. It manufactures and markets enzymes for biomedical use. The enzymes are used for manufacturers of medical devices, quality control labs and academic research institutions.